These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 16027329

  • 1. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM.
    Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [Abstract] [Full Text] [Related]

  • 2. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N, Fagan SP, Berger DH, Awad SS.
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [Abstract] [Full Text] [Related]

  • 3. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 4. [Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests].
    Hofmann WP, Rädle J, Moench C, Bechstein W, Zeuzem S.
    Z Gastroenterol; 2008 Nov; 46(11):1283-9. PubMed ID: 19012201
    [Abstract] [Full Text] [Related]

  • 5. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 7. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 8. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 9. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 10. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH, Son JH, Kim TW.
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [Abstract] [Full Text] [Related]

  • 11. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [Abstract] [Full Text] [Related]

  • 12. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M, Hernández Perera JC, Ramos Robaina L, Barroso Márquez L, González Rapado L, Cepero Valdés M, Hernández Rivero H, Abdo Cuza A, Valdés AR, Pérez Bernal J, Bernardos A.
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [Abstract] [Full Text] [Related]

  • 13. Early and late outcome of cardiac surgery in patients with liver cirrhosis.
    Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy H, Squire A, Adams DH.
    Liver Transpl; 2007 Jul; 13(7):990-5. PubMed ID: 17427174
    [Abstract] [Full Text] [Related]

  • 14. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG, Nicholson S, Richa J, Son C, Michalek J, Wolf SE, Stewart R.
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [Abstract] [Full Text] [Related]

  • 15. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC, Kim HJ, Choi WH, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI.
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [Abstract] [Full Text] [Related]

  • 17. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation.
    Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, Szymanik B, Jarosz K, Wójcicki M, Milkiewicz P.
    Transplant Proc; 2009 Oct; 41(8):3114-6. PubMed ID: 19857689
    [Abstract] [Full Text] [Related]

  • 18. Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes.
    An Y, Xiao YB, Zhong QJ.
    Eur Surg Res; 2007 Oct; 39(2):67-74. PubMed ID: 17283429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.